Maengjo Kim

Maengjo Kim

Auto-generated profile, based on publicly available information

Maengjo Kim

Mitochondria and Metabolism Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98109, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Cell Metabolism
Verified
Journal Article
Closed access
TLTao Li
Tao Li
ZZZhen Zhang
Zhen Zhang
SJStephen C Kolwicz Jr.
Stephen C Kolwicz Jr.
LALauren Abell
Lauren Abell
NRNathan D. Roe
Nathan D. Roe
RTRong Tian
Rong Tian

1 August 2008 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
MKMaengjo Kim
Maengjo Kim
JOJae Kyun Oh
Jae Kyun Oh
SSSusumu Sakata
Susumu Sakata
ILIifan Liang
Iifan Liang
WPWooJin Park
WooJin Park
Djamel LebecheDjamel Lebeche
Djamel Lebeche

14 March 2014 in Circulation Research
Verified
Journal Article
Closed access
PDF file
MKMaengjo Kim
Maengjo Kim
RHRoger W. Hunter
Roger W. Hunter
LGLorena Garcia-Menendez
Lorena Garcia-Menendez
GGGuohua Gong
Guohua Gong
YYYu-Ying Yang
Yu-Ying Yang
RTRong Tian
Rong Tian
Rationale:: AMP-activated protein kinase is a master regulator of cell metabolism and an attractive drug target for cancer and metabolic and cardiovascular diseases. Point mutations in the regulatory γ2-subunit of AMP-activated protein kinase (encoded by Prkag2 gene) caused a unique form of human cardiomyopathy characterized by cardiac hypertrophy, ventricular preexcitation, and glycogen storage. Understanding the disease mechanisms of Prkag2 cardiomyopathy is not only beneficial for the patients but also critical to the use of AMP-activated protein kinase as a drug target. Objective:: We sought to identify the pro–growth-signaling pathway(s) triggered by Prkag2 mutation and to distinguish it from the secondary response to glycogen storage. Methods and Results:: In a mouse model of N488I mutation of the Prkag2 gene (R2M), we rescued the glycogen storage phenotype by genetic inhibition of glucose-6-phosphate–stimulated glycogen synthase activity. Ablation of glycogen storage eliminated the ventricular preexcitation but did not affect the excessive cardiac growth in R2M mice. The progrowth effect in R2M hearts was mediated via increased insulin sensitivity and hyperactivity of Akt, resulting in activation of mammalian target of rapamycin and inactivation of forkhead box O transcription factor–signaling pathways. Consequently, cardiac myocyte proliferation during the postnatal period was enhanced in R2M hearts followed by hypertrophic growth in adult hearts. Inhibition of mammalian target of rapamycin activity by rapamycin or restoration of forkhead box O transcription factor activity by overexpressing forkhead box O transcription factor 1 rescued the abnormal cardiac growth. Conclusions:: Our study reveals a novel mechanism for Prkag2 cardiomyopathy, independent of glycogen storage. The role of γ2-AMP-activated protein kinase in cell growth also has broad implications in cardiac development, growth, and regeneration.

27 October 2017 in Circulation Research
Verified
Journal Article
Closed access
PDF file
YCYang Cao
Yang Cao
NBNaveen Bojjireddy
Naveen Bojjireddy
MKMaengjo Kim
Maengjo Kim
TLTao Li
Tao Li
PZPeiyong Zhai
Peiyong Zhai
RTRong Tian
Rong Tian
Rationale:: AMPK (AMP-activated protein kinase) is a heterotrimeric protein that plays an important role in energy homeostasis and cardioprotection. Two isoforms of each subunit are expressed in the heart, but the isoform-specific function of AMPK remains unclear. Objective:: We sought to determine the role of γ2-AMPK in cardiac stress response using bioengineered cell lines and mouse models containing either isoform of the γ-subunit in the heart. Methods and Results:: We found that γ2 but not γ1 or γ3 subunit translocated into nucleus on AMPK activation. Nuclear accumulation of AMPK complexes containing γ2-subunit phosphorylated and inactivated RNA Pol I (polymerase I)–associated transcription factor TIF-IA at Ser-635, precluding the assembly of transcription initiation complexes for rDNA. The subsequent downregulation of pre-rRNA level led to attenuated endoplasmic reticulum (ER) stress and cell death. Deleting γ2-AMPK led to increases in pre-rRNA level, ER stress markers, and cell death during glucose deprivation, which could be rescued by inhibition of rRNA processing or ER stress. To study the function of γ2-AMPK in the heart, we generated a mouse model with cardiac-specific deletion of γ2-AMPK (cardiac knockout [cKO]). Although the total AMPK activity was unaltered in cKO hearts because of upregulation of γ1-AMPK, the lack of γ2-AMPK sensitizes the heart to myocardial ischemia/reperfusion injury. The cKO failed to suppress pre-rRNA level during ischemia/reperfusion and showed a greater infarct size. Conversely, cardiac-specific overexpression of γ2-AMPK decreased ribosome biosynthesis and ER stress during ischemia/reperfusion insult, and the infarct size was reduced. Conclusions:: The γ2-AMPK translocates into the nucleus to suppress pre-rRNA transcription and ribosome biosynthesis during stress, thus ameliorating ER stress and cell death. Increased γ2-AMPK activity is required to protect against ischemia/reperfusion injury. Our study reveals an isoform-specific function of γ2-AMPK in modulating ribosome biosynthesis, cell survival, and cardioprotection.

1 October 2011 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
MKMaengjo Kim
Maengjo Kim
RTRong Tian
Rong Tian

1 November 2016 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
YCYong Seon Choi
Yong Seon Choi
AMAna Barbosa Marcondes de Mattos
Ana Barbosa Marcondes de Mattos
DSDan Shao
Dan Shao
TLTao Li
Tao Li
MNMiranda Nabben
Miranda Nabben
SJStephen C Kolwicz Jr.
Stephen C Kolwicz Jr.